ArticleDiscover mental health2025
Depression and associated factors among people with epilepsy at Wolaita Sodo University Hospital, South Ethiopia.
Article in Discover mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and associated factors of depression among adult patients with epilepsy in Ethiopia: a systematic review and meta-analysis, 2025.BMC psychiatry · 2025Pooled it
- Association of depression and epilepsy in rural northern Rwanda: a prospective longitudinal study with a patient-centered approach.Epilepsy & behavior reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEpilepsy is one of the most common neurological disorders in the world and contributes to various psychiatric illnesses. Depression is one of the most frequent comorbid psychiatric disorders that affect the quality of life in people with epilepsy. Despite this impact, depression continues to be under-recognized and undertreated. Therefore, this study aimed to assess the magnitude of depression and its associated factors among people with epilepsy at Wolaita Sodo University Hospital, South Ethiopia, 2021.
methodsA hospital-based cross-sectional study was conducted from April 2021 to May 2021. A systematic random sampling technique was used to select 423 samples of people with epilepsy, and interviewer-administered structured questionnaires were employed. The Patient Health Questionnaire with 9 items was used to assess depression. A logistic regression model was used to determine the association between the outcome and independent variables. A 95% CI and odds ratio with a corresponding p-value < 0.05 were used to determine the strength of association.
resultThe overall magnitude of depression among people with epilepsy in this study was 49.2%. Educational status; unable to read and write (AOR = 3.43, 95% CI 1.09, 10.7), being female (AOR = 2.54, 95% CI 1.43, 4.52), perceived stigma (AOR = 5.96, 95% CI 2.88, 12.3), poor social support (AOR = 2.88, 95% CI 1.28, 6.48), poor medication adherence (AOR = 4.60, 95% CI 2.46, 8.63), and seizure frequency above 5 times per month (AOR = 5.59, 95% CI 1.72, 18.1) were independent predictors of depression among people with epilepsy at p-value < 0.05. CONCLUSION AND RECOMMENDATION: In this study nearly half of the people with epilepsy had depression. Educational status; inability to read and write, being female, perceived stigma, poor social support, poor medication adherence, and seizure frequency of above 5 times per month were independent predictors of depression among people with epilepsy. Therefore, screening depression in people with epilepsy and appropriate management critically needed attention to reduce the effects of the problems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.